Home / Journals Bioprocess Engineering / Advances in Biochemical Engineering and Biotechnology
Advances in Biochemical Engineering and Biotechnology
Submission Deadline: Nov. 25, 2019

This special issue currently is open for paper submission and guest editor application.

Join as Guest Editor Submit to Special Issue
Lead Guest Editor
Peter Blas
Department of Science, The Kibworth School, Leicester, Leicestershire, UK
Guest Editor
Guest Editors play a significant role in a special issue. They maintain the quality of published research and enhance the special issue’s impact. If you would like to be a Guest Editor or recommend a colleague as a Guest Editor of this special issue, please Click here to fulfill the Guest Editor application.
Guidelines for Submission
Manuscripts can be submitted until the expiry of the deadline. Submissions must be previously unpublished and may not be under consideration elsewhere.
Papers should be formatted according to the guidelines for authors (see: http://www.sciencepublishinggroup.com/journal/guideforauthors?journalid=535). By submitting your manuscripts to the special issue, you are acknowledging that you accept the rules established for publication of manuscripts, including agreement to pay the Article Processing Charges for the manuscripts. Manuscripts should be submitted electronically through the online manuscript submission system at http://www.sciencepublishinggroup.com/login. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal and will be listed together on the special issue website.
Published Papers
The special issue currently is open for paper submission. Potential authors are humbly requested to submit an electronic copy of their complete manuscript by clicking here.

Special Issue Flyer (PDF)

Please download to know all details of the
Special Issue

Introduction
This special issue will review the current research available around the world about Gene therapy. It will explain what gene therapy is available to the general public and explain how difficult is it for the FDA to pass AAV gene therapies. It will also explain how the bioprocessing of AAV is achieved, and take the reader into what the drawbacks are in industry and biomanufacturing? It will highlight the current gene therapies on the market, and why more are not available. It will finish with what the future may hold for gene therapy.

Aims and Scope:

  1. Gene therapy review
  2. Biomanufacturing
  3. Accessibility
  4. Current therapies available
  5. Drawbacks to gene therapy
  6. Future Challenges
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186